FDA approves Zepbound for sleep apnea
The U.S. Food and Drug Administration (FDA) recently approved Zepbound (tirzepatide) as the first prescription drug for obstructive sleep apnea. Zepbound was first approved for chronic weight...
View ArticleFDA approves first generic once-daily GLP-1 medication
As glucagon-like peptide-1 (GLP-1) receptor agonists continue to surge in popularity, the U.S. Food and Drug Administration approved the second generic in this class of medications: liraglutide...
View ArticleFDA approves Ozempic for kidney disease
The blockbuster GLP-1 drug Ozempic has received approval for yet another chronic medical condition. The U.S. Food and Drug Administration (FDA) expanded Ozempic’s indication to reduce the risk of...
View ArticleWhat you should know about microdosing Ozempic
Ozempic (semaglutide), an injectable diabetes medication manufactured by Novo Nordisk, is well-known for helping people lose a significant amount of weight and keep it off. However, taking this...
View ArticleFDA approves first rapid-acting insulin biosimilar
People with diabetes who need to use insulin now have another option to help manage blood sugar levels. The U.S. Food and Drug Administration (FDA) approved Merilog (insulin-aspart-szjj) to improve...
View ArticleFDA approves generic Xarelto
On March 4, 2025, the U.S. Food and Drug Administration (FDA) announced its approval of the first generic form of Xarelto (rivaroxaban), a popular anticoagulant medication. The approval is for the 2.5...
View Article